UPDATE: FDA expands recall of blood pressure medication to include 13K+ bottles | Local News

UPDATE: The recall of a blood pressure medication has been expanded to a Class II recall involving more than 13,000 bottles.

Inventia Healthcare Limited initiated the recall of 25 mg Chlorthalidone Tablets, USP. Each bottle has 100 tablets and an expiration date of April 2027.

The recall is due to “failed dissolution specifications,” according to the U.S. Food and Drug Administration.

The FDA classifies a Class II recall as when a product can cause temporary or medically reversible adverse health consequences.

Chlorthalidone Tablets were distributed nationwide in the U.S. The tablets are a prescription diuretic medication (water pills) used to treat high blood pressure and fluid retention.

Recall #: D-0852-2026

Batch #: RISA24002

There are now 13,567 bottles impacted by the recall.

The FDA updated the recall on September 17, 2026. The initial recall of the Chlorthalidone Tablets was not previously classified; the update classifies the recall and expands the number of affected bottles.

PREVIOUS STORY: The Food and Drug Administration (FDA) has issued a recall for thousands of bottles of a commonly prescribed blood pressure medication after testing revealed “failed dissolution specifications,” and according to MedxDrg, this means the drug may not break down properly in the body and could be less effective than intended.

In total, 11,460 bottles of chlorthalidone tablets, USP, 25 mg are affected. The recalled products have an expiration date of April 2027 and include 100-count bottles labeled batch RISA24001 as well as 1,000-count bottles labeled RISB24002.

Chlorthalidone is a water pill, or diuretic, often prescribed to help lower high blood pressure and reduce fluid buildup linked to conditions such as heart failure, kidney or liver disease, or certain steroid or hormone treatments, according to medical references such as the Mayo Clinic.